NextCure Short Long Term Debt Total vs Common Stock Shares Outstanding Analysis

NXTC Stock

USD 0.76 0 0.39%

NextCure financial indicator trend analysis is infinitely more than just investigating NextCure recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NextCure is a good investment. Please check the relationship between NextCure Short Long Term Debt Total and its Common Stock Shares Outstanding accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NextCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.

Short Long Term Debt Total vs Common Stock Shares Outstanding

Short Long Term Debt Total vs Common Stock Shares Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NextCure Short Long Term Debt Total account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have almost identical trend.

The correlation between NextCure's Short Long Term Debt Total and Common Stock Shares Outstanding is 0.93. Overlapping area represents the amount of variation of Short Long Term Debt Total that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of NextCure, assuming nothing else is changed. The correlation between historical values of NextCure's Short Long Term Debt Total and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt Total of NextCure are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Short Long Term Debt Total i.e., NextCure's Short Long Term Debt Total and Common Stock Shares Outstanding go up and down completely randomly.

Correlation Coefficient

0.93

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Short Long Term Debt Total

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Most indicators from NextCure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NextCure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NextCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.The current year's Sales General And Administrative To Revenue is expected to grow to 1.25, whereas Selling General Administrative is forecasted to decline to about 14.9 M.

	2022	2023	2024	2025 (projected)
Reconciled Depreciation	4.1M	3.9M	4.4M	3.7M
Total Operating Expenses	75.9M	67.6M	77.8M	56.6M

Reconciled Depreciation Total Operating Expenses

NextCure fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Capital Lease Obligations	Other Current Assets	Other Stockholder Equity
Total Assets		0.67	0.92	0.93	0.94	0.44	0.92	0.74	0.6	-0.26	-0.52	0.7	0.3	0.82	0.58	0.76	0.85	1.0	0.81	0.66	0.85	-0.26	0.81	0.27	0.77	0.59
Short Long Term Debt Total	0.67		0.89	0.58	0.77	-0.02	0.83	0.85	0.13	0.16	-0.9	0.66	-0.1	0.85	0.82	0.41	0.84	0.66	0.95	0.93	0.84	-0.57	0.96	0.7	0.92	0.9
Other Current Liab	0.92	0.89		0.81	0.96	0.16	0.98	0.88	0.34	0.0	-0.76	0.75	0.05	0.93	0.78	0.64	0.93	0.91	0.97	0.88	0.93	-0.52	0.97	0.53	0.92	0.83
Total Current Liabilities	0.93	0.58	0.81		0.8	0.65	0.79	0.66	0.78	-0.46	-0.48	0.7	0.51	0.78	0.61	0.75	0.78	0.93	0.71	0.53	0.78	-0.03	0.71	0.34	0.58	0.46
Total Stockholder Equity	0.94	0.77	0.96	0.8		0.16	0.99	0.77	0.37	0.06	-0.59	0.66	-0.01	0.85	0.61	0.74	0.93	0.94	0.89	0.76	0.93	-0.56	0.89	0.32	0.85	0.69
Other Liab	0.44	-0.02	0.16	0.65	0.16		0.13	-0.02	0.95	-0.86	0.12	0.13	0.87	0.09	-0.02	0.37	0.18	0.46	0.03	-0.14	0.18	0.68	0.04	-0.19	-0.01	-0.2
Net Tangible Assets	0.92	0.83	0.98	0.79	0.99	0.13		0.8	0.34	0.08	-0.67	0.67	-0.03	0.88	0.68	0.69	0.95	0.92	0.94	0.82	0.95	-0.58	0.94	0.41	0.88	0.76
Property Plant And Equipment Net	0.74	0.85	0.88	0.66	0.77	-0.02	0.8		0.09	-0.05	-0.85	0.93	0.1	0.97	0.87	0.51	0.7	0.72	0.91	0.94	0.7	-0.44	0.9	0.71	0.83	0.93
Current Deferred Revenue	0.6	0.13	0.34	0.78	0.37	0.95	0.34	0.09		-0.69	0.02	0.19	0.71	0.24	0.1	0.55	0.43	0.61	0.21	-0.02	0.43	0.45	0.22	-0.1	0.12	-0.1
Net Debt	-0.26	0.16	0.0	-0.46	0.06	-0.86	0.08	-0.05	-0.69		-0.12	-0.27	-1.0	-0.05	0.03	-0.18	0.14	-0.27	0.09	0.12	0.14	-0.85	0.09	0.16	0.1	0.12
Retained Earnings	-0.52	-0.9	-0.76	-0.48	-0.59	0.12	-0.67	-0.85	0.02	-0.12		-0.7	0.07	-0.81	-0.95	-0.16	-0.64	-0.5	-0.86	-0.91	-0.64	0.48	-0.86	-0.91	-0.79	-0.91
Accounts Payable	0.7	0.66	0.75	0.7	0.66	0.13	0.67	0.93	0.19	-0.27	-0.7		0.32	0.92	0.77	0.6	0.55	0.69	0.75	0.78	0.55	-0.21	0.75	0.6	0.63	0.78
Cash	0.3	-0.1	0.05	0.51	-0.01	0.87	-0.03	0.1	0.71	-1.0	0.07	0.32		0.11	0.03	0.22	-0.09	0.31	-0.04	-0.07	-0.09	0.82	-0.04	-0.11	-0.07	-0.08
Non Current Assets Total	0.82	0.85	0.93	0.78	0.85	0.09	0.88	0.97	0.24	-0.05	-0.81	0.92	0.11		0.86	0.66	0.81	0.81	0.93	0.9	0.81	-0.45	0.93	0.68	0.8	0.86
Non Currrent Assets Other	0.58	0.82	0.78	0.61	0.61	-0.02	0.68	0.87	0.1	0.03	-0.95	0.77	0.03	0.86		0.25	0.66	0.57	0.85	0.86	0.66	-0.41	0.83	0.93	0.7	0.84
Other Assets	0.76	0.41	0.64	0.75	0.74	0.37	0.69	0.51	0.55	-0.18	-0.16	0.6	0.22	0.66	0.25		0.7	0.76	0.53	0.34	0.7	-0.22	0.55	0.03	0.39	0.28
Long Term Debt	0.85	0.84	0.93	0.78	0.93	0.18	0.95	0.7	0.43	0.14	-0.64	0.55	-0.09	0.81	0.66	0.7		0.85	0.9	0.73	1.0	-0.58	0.9	0.45	0.8	0.65
Cash And Short Term Investments	1.0	0.66	0.91	0.93	0.94	0.46	0.92	0.72	0.61	-0.27	-0.5	0.69	0.31	0.81	0.57	0.76	0.85		0.8	0.65	0.85	-0.25	0.8	0.25	0.76	0.57
Common Stock Total Equity	0.81	0.95	0.97	0.71	0.89	0.03	0.94	0.91	0.21	0.09	-0.86	0.75	-0.04	0.93	0.85	0.53	0.9	0.8		0.95	0.9	-0.58	1.0	0.65	0.93	0.92
Common Stock Shares Outstanding	0.66	0.93	0.88	0.53	0.76	-0.14	0.82	0.94	-0.02	0.12	-0.91	0.78	-0.07	0.9	0.86	0.34	0.73	0.65	0.95		0.73	-0.57	0.95	0.71	0.91	0.99
Long Term Debt Total	0.85	0.84	0.93	0.78	0.93	0.18	0.95	0.7	0.43	0.14	-0.64	0.55	-0.09	0.81	0.66	0.7	1.0	0.85	0.9	0.73		-0.58	0.9	0.45	0.8	0.65
Non Current Liabilities Total	-0.26	-0.57	-0.52	-0.03	-0.56	0.68	-0.58	-0.44	0.45	-0.85	0.48	-0.21	0.82	-0.45	-0.41	-0.22	-0.58	-0.25	-0.58	-0.57	-0.58		-0.58	-0.39	-0.56	-0.55
Capital Surpluse	0.81	0.96	0.97	0.71	0.89	0.04	0.94	0.9	0.22	0.09	-0.86	0.75	-0.04	0.93	0.83	0.55	0.9	0.8	1.0	0.95	0.9	-0.58		0.64	0.93	0.91
Capital Lease Obligations	0.27	0.7	0.53	0.34	0.32	-0.19	0.41	0.71	-0.1	0.16	-0.91	0.6	-0.11	0.68	0.93	0.03	0.45	0.25	0.65	0.71	0.45	-0.39	0.64		0.49	0.71
Other Current Assets	0.77	0.92	0.92	0.58	0.85	-0.01	0.88	0.83	0.12	0.1	-0.79	0.63	-0.07	0.8	0.7	0.39	0.8	0.76	0.93	0.91	0.8	-0.56	0.93	0.49		0.89
Other Stockholder Equity	0.59	0.9	0.83	0.46	0.69	-0.2	0.76	0.93	-0.1	0.12	-0.91	0.78	-0.08	0.86	0.84	0.28	0.65	0.57	0.92	0.99	0.65	-0.55	0.91	0.71	0.89

Click cells to compare fundamentals

NextCure Account Relationship Matchups

NextCure fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	306.6M	242.4M	184.2M	128.0M	147.2M	217.6M
Short Long Term Debt Total	5.1M	3.5M	7.1M	6.6M	7.6M	4.4M
Other Current Liab	4.8M	4.7M	4.3M	3.9M	4.5M	4.2M
Total Current Liabilities	10.3M	6.6M	9.1M	6.9M	7.9M	9.6M
Total Stockholder Equity	293.7M	233.4M	167.5M	114.4M	131.6M	166.4M
Other Liab	16.3M	792K	2.4M	899K	809.1K	768.6K
Net Tangible Assets	321.5M	293.7M	233.4M	167.5M	192.7M	173.2M
Property Plant And Equipment Net	15.8M	14.0M	16.9M	13.4M	15.4M	14.7M
Net Debt	(29.3M)	(12.3M)	(19.5M)	(6.5M)	(7.4M)	(7.8M)
Retained Earnings	(117.6M)	(187.0M)	(261.8M)	(324.5M)	(292.0M)	(277.4M)
Accounts Payable	3.9M	1.9M	4.3M	2.3M	2.7M	2.8M
Cash	32.8M	12.3M	26.6M	13.1M	11.8M	11.2M
Non Current Assets Total	18.7M	14.6M	20.2M	15.3M	17.6M	16.8M
Non Currrent Assets Other	1.1M	577K	1.7M	1.9M	2.2M	2.3M
Other Assets	436K	4.1M	2.9M	577K	3.3M	0.0
Cash And Short Term Investments	283.4M	219.6M	159.9M	108.3M	124.5M	196.3M
Common Stock Shares Outstanding	27.5M	27.6M	27.7M	27.8M	32.0M	23.0M
Short Term Investments	250.7M	207.3M	133.3M	95.2M	109.5M	155.1M
Liabilities And Stockholders Equity	306.6M	242.4M	184.2M	128.0M	147.2M	217.6M
Non Current Liabilities Total	2.6M	2.4M	7.5M	6.7M	6.1M	5.8M
Capital Surpluse	402.5M	410.6M	421.0M	430.8M	495.4M	305.3M
Other Current Assets	4.5M	8.2M	4.1M	4.4M	5.1M	4.0M
Other Stockholder Equity	410.6M	421.0M	430.8M	439.1M	505.0M	275.2M
Total Liab	12.9M	9M	16.6M	13.6M	12.3M	11.6M
Net Invested Capital	297.2M	233.4M	167.5M	114.4M	131.6M	168.0M
Property Plant And Equipment Gross	15.8M	26.7M	33.5M	33.7M	38.7M	22.5M
Total Current Assets	288.0M	227.8M	164.0M	112.7M	129.6M	200.8M
Accumulated Other Comprehensive Income	779K	(663K)	(1.5M)	(222K)	(255.3K)	(268.1K)
Net Working Capital	277.7M	221.2M	154.9M	105.8M	121.7M	191.1M
Short Term Debt	1.8M	1.7M	518K	656K	754.4K	1.0M
Property Plant Equipment	12.1M	15.8M	14.0M	11.9M	13.7M	13.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

When determining whether NextCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NextCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nextcure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nextcure Stock:

How To Invest In NextCure

Details

Is NextCure Stock a good investment?

Details

What is NextCure's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NextCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.

You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NextCure. If investors know NextCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NextCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.10)

Quarterly Revenue Growth

(1.00)

Return On Assets

(0.33)

Return On Equity

(0.58)

The market value of NextCure is measured differently than its book value, which is the value of NextCure that is recorded on the company's balance sheet. Investors also form their own opinion of NextCure's value that differs from its market value or its book value, called intrinsic value, which is NextCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NextCure's market value can be influenced by many factors that don't directly affect NextCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between NextCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if NextCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NextCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

NextCure Short Long Term Debt Total vs Common Stock Shares Outstanding Analysis

Short Long Term Debt Total vs Common Stock Shares Outstanding

Short Long Term Debt Total vs Common Stock Shares Outstanding Correlation Analysis

Correlation Coefficient

Short Long Term Debt Total

Common Stock Shares Outstanding

NextCure fundamental ratios Correlations

NextCure Account Relationship Matchups

High Positive Relationship

High Negative Relationship

NextCure fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Long Term Debt Total	+ 1.0	Long Term Debt
Capital Surpluse	+ 1.0	Common Stock Total Equity
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Other Stockholder Equity	+ 0.99	Common Stock Shares Outstanding
Net Tangible Assets	+ 0.98	Other Current Liab

Cash	- 1.0	Net Debt
Non Currrent Assets Other	- 0.95	Retained Earnings
Other Stockholder Equity	- 0.91	Retained Earnings
Capital Lease Obligations	- 0.91	Retained Earnings
Common Stock Shares Outstanding	- 0.91	Retained Earnings
Retained Earnings	- 0.9	Short Long Term Debt Total